Breaking News, Trials & Filings

Trials & Filings in Brief: Nov. 27, 2013

Mylan-Biocon, Cerecor, ARMO BioSciences, GSK, J&J, and more

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Phase I ARMO BioSciences has initiated Phase I trial of AM0010 in advanced solid tumors…read more Threshold Pharmaceuticals posted early data from the Phase I portion of the investigator-sponsored Phase I/II trial of its investigational hypoxia-targeted drug TH-302 in combination with Avastin (bevacizumab) in patients with recurrent glioblastoma following bevacizumab failure … read more Phase III Cubist Pharmaceuticals Phase III trial of ceftolozane/tazobactam in complicated urinary tract infe...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters